The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome

被引:7
作者
Akcay, Adnan Burak [1 ]
Camsari, Ahmet [1 ]
Ozcan, Turkay [1 ]
Cicek, Dilek [1 ]
Akkus, Necdet [1 ]
Seyis, Sabri [1 ]
Cimen, Burak [2 ]
Celebi, Baris [1 ]
Doven, Oben [1 ]
Cin, Gokhan [1 ]
机构
[1] Mersin Univ, Med Fac, Dept Cardiol, Mersin, Turkey
[2] Mersin Univ, Med Fac, Dept Biochem, Mersin, Turkey
来源
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY | 2011年 / 39卷 / 05期
关键词
Angina pectoris; aryldialkylphosphatase/blood; coronary artery disease; metabolic syndrome X;
D O I
10.5543/tkda.2011.01382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We investigated the correlation of serum paraoxonase-1 (PON-1) activity with coronary artery disease (CAD) in patients with metabolic syndrome (MetS). Study design: The study included 21 patients (mean age 55 +/- 9 years) with MetS, stable angina pectoris, and angiographically shown CAD, 24 patients (mean age 51 +/- 10 years) with MetS and angiographically normal coroner arteries, and 28 healthy controls (mean age 49 +/- 12 years). Demographic and clinical characteristics, insulin levels, homeostasis model assessment of insulin resistance index, and PON- 1 activity were assessed in all the groups. Severity of CAD was assessed using the Gensini score. Results: Paraoxonase-1 activity was significantly lower in patients with MetS compared to the control group (p= 0.02). The two MetS groups with and without CAD exhibited similar characteristics in all the parameters including PON-1 activity (p>0.05). Univariate correlation analysis performed in MetS-CAD patients showed a significant negative correlation between the Gensini score and PON-1 activity (r=-0.48, p=0.02). The overall PON- 1 activity of all the subjects showed no correlation with the parameters examined. Conclusion: Decreased PON-1 activity in patients with MetS compared to the control group suggests increased oxidative stress in MetS. Detection of similar PON-1 activity levels in MetS groups with and without CAD suggests that disturbance of oxidative- antioxidative balance occurs before the development of CAD. The negative correlation between the Gensini score and PON-1 activity implies that decreased PON-1 activity may be one of the etiologic causes of atherosclerotic progress in MetS.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 24 条
[1]   Serum paraoxonase after myocardial infarction [J].
Ayub, A ;
Mackness, MI ;
Arrol, S ;
Mackness, B ;
Patel, J ;
Durrington, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) :330-335
[2]   THE FREE-RADICAL SYSTEM IN ISCHEMIC-HEART-DISEASE [J].
CHANDRA, M ;
CHANDRA, N ;
AGRAWAL, R ;
KUMAR, A ;
GHATAK, A ;
PANDEY, VC .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1994, 43 (02) :121-125
[3]   Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome [J].
Garin, MCB ;
Kalix, B ;
Morabia, A ;
James, RW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :2264-2269
[4]  
Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x
[5]   Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease [J].
Granér, M ;
James, RW ;
Kahri, J ;
Nieminen, MS ;
Syvänne, M ;
Taskinen, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) :2429-2435
[6]   Paraoxonase and arylesterase activities in coronary artery disease [J].
Gur, M. ;
Aslan, M. ;
Yildiz, A. ;
Demirbag, R. ;
Yilmaz, R. ;
Selek, S. ;
Erel, O. ;
Ozdogru, I. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (11) :779-787
[7]   Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes [J].
Kabaroglu, C ;
Mutaf, I ;
Boydak, B ;
Özmen, D ;
Habif, S ;
Erdener, D ;
Parildar, Z ;
Bayindir, O .
ACTA CARDIOLOGICA, 2004, 59 (06) :606-611
[8]   Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis [J].
Kaplan, M ;
Hayek, T ;
Raz, A ;
Coleman, R ;
Dornfeld, L ;
Vaya, J ;
Aviram, M .
JOURNAL OF NUTRITION, 2001, 131 (08) :2082-2089
[9]  
Letellier C, 2002, DIABETES METAB, V28, P297
[10]   Serum paraoxonase activity in patients with type I diabetes compared to healthy controls [J].
Mackness, B ;
Durrington, PN ;
Boulton, AJM ;
Hine, D ;
Mackness, MI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (04) :259-264